The share of patients exposed to high out-of-pocket costs, or those $125 or more, has increased 44% since just 2013. This is due to changes in benefit design, and patients are feeling the effects. Learn more: https://onphr.ma/2zTF337 pic.twitter.com/0QK
16:30 EDT 4 Oct 2018 |
PhRMA
More From BioPortfolio on "The share of patients exposed to high out-of-pocket costs, or those $125 or more, has increased 44% since just 2013. This is due to changes in benefit design, and patients are feeling the effects. Learn more: https://onphr.ma/2zTF337 pic.twitter.com/0QK"